New and emerging therapies for the treatment of rheumatoid arthritis
Michael G FeelyDivision of Rheumatology and Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, USAAbstract: The introduction of tumor necrosis factor (TNF) inhibitors in the late 1990s ­significantly changed the therape...
Guardado en:
Autor principal: | Michael G Feely |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f1850835f254dfabf88d3d1b8990c43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013) -
Certolizumab in the long-term treatment of rheumatoid arthritis
por: Scott DL, et al.
Publicado: (2011) -
Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis EM, et al.
Publicado: (2014) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021) -
Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009)